The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Toxicol.
Sec. Regulatory Toxicology
Volume 7 - 2025 |
doi: 10.3389/ftox.2025.1525089
Selection of the critical effect size alters hazard characterizationa retrospective analysis of key studies used for risk assessments of PFAS
Provisionally accepted- Karolinska Institutet (KI), Solna, Sweden
Regulatory values for per-and polyfluoroalkyl substances vary widely across agencies, creating inconsistencies that challenge effective risk management and public health communication. These differences often stem from methodological choices in determining points of departure (PoDs), specifically in the selection of critical effect size (CES) and modeling framework for benchmark dose (BMD) analysis. This study investigates the impact of CES selection on hazard characterization by analyzing how variations in CES influence resulting PoDs and health-based guidance values.A retrospective analysis of key studies from four regulatory PFAS risk assessments was conducted, covering both animal and epidemiological data (thyroid hormone, cholesterol, and vaccine response). CES options compared included 5%, 10%, one standard deviation from background, and a generalized effect size theory, using both frequentist and Bayesian statistics.The findings show that CES selection and statistical approach substantially affect BMD estimates such as the lower bound BMD (BMDL) of the respective confidence interval or credible interval; with larger CES values and Bayesian modeling yielding more biologically relevant, stable results. For instance, Bayesian methods provided narrower credible intervals, minimizing overly conservative assessments, compared to frequentist methods at lower CES levels. However, in comparison to the PoD previously derived by EFSA, the results generally resulted in lower values. In conclusion, this study supports the use of a flexible, endpoint-specific CES with Bayesian model averaging, which may enhance the accuracy and consistency of PFAS guidance values, offering a more robust foundation for regulatory risk assessments.
Keywords: Benchmark dose modeling, Bayesian benchmark dose modeling, Critical Effect Size, Per-and polyfluoroalkyl substances, PFAS, Risk Assessment
Received: 08 Nov 2024; Accepted: 21 Jan 2025.
Copyright: © 2025 Brunken, Vieira Silva and Öberg. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Mattias Öberg, Karolinska Institutet (KI), Solna, Sweden
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.